Use of glycan as biomarkers for autoimmune diseases
Abstract:
The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0